James H. Wikel
Chief Tech/Sci/R&D Officer at Apexian Pharmaceuticals, Inc.
Profile
James H.
Wikel is currently the Head of Research & Development at Apexian Pharmaceuticals, Inc. He was previously a Principal at Eli Lilly & Co. from 1971 to 2004 and the Chief Technology Officer at Coalesix, Inc. He received his undergraduate and graduate degrees from Marshall University.
James H. Wikel active positions
| Companies | Position | Start |
|---|---|---|
Apexian Pharmaceuticals, Inc.
 Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Chief Tech/Sci/R&D Officer | - |
Former positions of James H. Wikel
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Coalesix, Inc. | Chief Tech/Sci/R&D Officer | - |
Training of James H. Wikel
| Marshall University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
| Coalesix, Inc. | |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- James H. Wikel
